August 22nd 2025
The recall was in response to particulate matter found in the container.
Annex 1 Misses the Mark–Expanded Version
March 14th 2018A previously published article presented difficulties with the revised European guidelines on sterile manufacturing. The authors included a brief summary of the comments developed on the draft document. This article expands upon that summary, outlines the authors' rationale, and highlights the most difficult aspects of the revision draft.
Hospira Recalls Labetalol Hydrochloride Due to Cracked Vials
February 23rd 2018The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.